Vitreous amyloidosis as the presenting symptom of familial amyloid polyneuropathy TTR Val30Met in a Portuguese patient

Case Reports in Ophthalmology

Volumn 5, Issue 1, 2014, Pages 92-97

  Seca, Mariana ^a,b   Ferreira, Natália ^a   Coelho, Teresa ^a,b  

^a Institute of Biomedical Sciences Abel Salazar   (Portugal)

^b HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

Familial amyloid polyneuropathy; Transthyretin; Vitreous amyloidosis

Indexed keywords

PREALBUMIN; AMYLOID;

AGED; AMYLOIDOSIS; ARTICLE; BIOMICROSCOPY; BLURRED VISION; CASE REPORT; CATARACT; CILIARY DISK; DIZZINESS; ETHNIC GROUP; EYE FUNDUS; FAINTNESS; FAMILIAL AMYLOID POLYNEUROPATHY; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMPLANTED HEART PACEMAKER; LENS IMPLANTATION; MALE; PHACOEMULSIFICATION; POINT MUTATION; PORTUGUESE; PRIORITY JOURNAL; PSEUDOPHAKIA; SALIVARY GLAND BIOPSY; SECOND DEGREE ATRIOVENTRICULAR BLOCK; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION; VITRECTOMY; VITREOUS AMYLOIDOSIS; VITREOUS DISEASE; VITREOUS FLOATERS; VITREOUS OPACITY; CLINICAL FEATURE; DISEASE COURSE; DISEASE DURATION; FIRST DEGREE ATRIOVENTRICULAR BLOCK; GENE; GENE MUTATION; PACEMAKER IMPLANTATION; PORTUGAL; POSTOPERATIVE PERIOD; TTR GENE;

EID: 84900444159     PISSN: None     EISSN: 16632699     Source Type: Journal    
DOI: 10.1159/000360790     Document Type: Article

References (30)

1. Ando Y, Nakamura M, Araki S: Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005;62:1057-1062. (Pubitemid 41043725)
2. Benson MD, Kincaid JC: The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 2007;36:411-423. (Pubitemid 47512065)
3. Cavallaro T, Martone RL, Dwork AJ, Schon EA, Herbert J: The retinal pigment epithelium is the unique site of transthyretin synthesis in the rat eye. Invest Ophthalmol Vis Sci 1990;31:497-501. (Pubitemid 20117065)
4. Herbert J, Wilcox JN, Pham KT, Fremeau RT Jr, Zeviani M, Dwork A, et al: Transthyretin: a choroid plexus-specific transport protein in human brain. Neurology 1986;36:900-911. (Pubitemid 16098232)
5. Planté-Bordeneuve V, Said G: Familial amyloid polyneuropathy. Lancet Neurol 2011;10:1086-1097.
6. Sousa A, Coelho T, Barros J, Sequeiros J: Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Póvoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet 1995;60:512-521. (Pubitemid 26002118)
7. Ikeda S, Hanyu N, Hongo M, Yoshioka J, Oguchi H, Yanagisawa N, Kobayashi T, Tsukagoshi H, Ito N, Yokota T: Hereditary generalized amyloidosis with polyneuropathy. Clinicopathological study of 65 Japanese patients. Brain 1987;110:315-337. (Pubitemid 17055815)
8. Holmgren G, Holmberg E, Lindström A, Lindström E, Nordenson I, Sandgren O, Steen L, Svensson B, Lundgren E, von Gabain A: Diagnosis of familial amyloidotic polyneuropathy in Sweden by RFLP analysis. Clin Genet 1988;33:176-180. (Pubitemid 18068416)
9. Munar-Qués M, Saraiva MJ, Viader-Farré C, Zabay-Becerril JM, Mulet-Ferrer J: Genetic epidemiology of familial amyloid polyneuropathy in the Balearic Islands (Spain). Amyloid 2005;12:54-61. (Pubitemid 40896945)
10. Andrade C: A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952;75:408-427.
11. Kantarjian AD, DeJong RN: Familial primary amyloidosis with nervous system involvement. Neurology 1953;3:399-409.
12. Andersson R, Kassman T: Vitreous opacities in primary familial amyloidosis. Acta Ophthalmol (Copenh) 1968;46:441-447.
13. Monteiro JG, Martins AF, Figueira A, Saraiva MJ, Costa PP: Ocular changes in familial amyloidotic polyneuropathy with dense vitreous opacities. Eye 1991;5:99-105.
14. Beirão NM, Matos ME, Menéres MJ, Beirão IM, Costa PP, Torres PA: Vitreous surgery impact in glaucoma development in liver transplanted familial amyloidosis ATTR V30M Portuguese patients. Amyloid 2012;19:145-151.
15. Hara R, Kawaji T, Ando E, Ohya Y, Ando Y, Tanihara H: Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients. Arch Ophthalmol 2010;128:206-210.
16. Ando E, Ando Y, Okamura R, Uchino M, Ando M, Negi A: Ocular manifestations of familial amyloidotic polyneuropathy type I: long-term follow up. Br J Ophthalmol 1997;81:295-298. (Pubitemid 27196759)
17. Haraoka K, Ando Y, Ando E, Sandgren O, Hirata A, Nakamura M, Terazaki H, Tajiri T, Tanoue Y, Sun X, Okabe H, Tanihara H: Amyloid deposition in ocular tissues of patients with familial amyloidotic polyneuropathy (FAP). Amyloid 2002;9:183-189. (Pubitemid 35205208)
18. Ciulla TA, Tolentino F, Morrow JF, Dryja TP: Vitreous amyloidosis in familial amyloidotic polyneuropathy. Report of a case with the Val30Met transthyretin mutation. Surv Ophthalmol 1995;40:197-206.
19. Salvador F, Mateo C, Alegre J, Reventos A, García-Arumi J, Corcostegui B: Vitreous amyloidosis without systemic or familial involvement. Int Ophthalmol 1993-1994;17:355-357. (Pubitemid 24134943)
20. Ferry AP, Lieberman TW: Bilateral amyloidosis of the vitreous body without systemic involvement. Arch Ophthalmol 1976;94:982-991.
21. Ando E, Ando Y, Maruoka S, Sakai Y, Watanabe S, Yamashita R, Okumura R, Araki S: Ocular microangiopathy in familial amyloidotic polyneuropathy, type 1. Graefes Arch Clin Exp Ophthalmol 1992;230:1-5.
22. Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE: Tabulation of human transthyretin variants, 2003. Amyloid 2003;10:160-184. (Pubitemid 37372400)
23. Holmgren G, Hellman U, Lundgren HE, Sandgren O, Suhr OB: Impact of homozygosity for an amyloidogenic transthyretin mutation on phenotype and long term outcome. J Med Genet 2005;42:953-956. (Pubitemid 41811319)
24. Koga T, Ando E, Hirata A, Fukushima M, Kimura A, Ando Y, Negi A, Tanihara H: Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy. Am J Ophthalmol 2003;135:188-193. (Pubitemid 36151796)
25. Sandgren O: Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement. Surv Ophthalmol 1995;40:173-196.
26. Beirão NM, Matos E, Beirão I, Costa PP, Torres P: Recurrence of vitreous amyloidosis and need of surgical reintervention in Portuguese patients with familial amyloidosis ATTR V30M. Retina 2011;31:1373-1377.
27. Hitchings RA, Tripathi RC: Vitreous opacities in primary amyloid disease. A clinical, histochemical, and ultrastructural report. Br J Ophthalmol 1976;60:41-54.
28. Martone RL, Herbert J, Dwork A, Schon EA: Transthyretin is synthesized in the mammalian eye. Biochem Biophys Res Commun 1988;151:905-912. (Pubitemid 18081847)
29. Kawaji T, Ando Y, Nakamura M, Yamamoto K, Ando E, Takano A, Inomata Y, Hirata A, Tanihara H: Transthyretin synthesis in rabbit ciliary pigment epithelium. Exp Eye Res 2005;81:306-312. (Pubitemid 41208165)
30. Ando Y, Ando E, Tanaka Y, Yamashita T, Tashima K, Suga M, Uchino M, Negi A: De novo amyloid synthesis in ocular tissue in familial amyloidotic polyneuropathy after liver transplantation. Transplantation 1996;62:1037-1038. (Pubitemid 26360371)